newsfilter
← Latest News
PR Newswire·

Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

VICTORIA, BC, March 20, 2025 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage...